# Project Proposal, Draft 2 for Spring 2024


## Table of Contents

The [schedule of project presentations is found here](https://github.com/THOMASELOVE/500-classes-2024/blob/main/project/schedule.md).

1. [Sara Alqahtani](#sara-alqahtani)
2. [Naji Ayyash](#naji-ayyash)
3. [John Barron](#john-barron)
4. [Seth Bauer](#seth-bauer)
5. [Chris Benson](#chris-benson)
6. [Jesse Chen](#jesse-chen)
7. [Sid Dugar](#sid-dugar)
8. [Ava Fan](#ava-fan)
9. [Lent Mantshonyane](#lent-mantshonyane)
10. [Marie Masotya](#marie-masotya)
11. [Morgan McLoughlin](#morgan-mcloughlin)
12. [Lydia Mitchell](#lydia-mitchell)
13. [Hala Nas](#hala-nas)
14. [Anya Nazarenko](#anya-nazarenko)
15. [Anthony Orsino](#anthony-orsino)
16. [Aman Pande](#aman-pande)
17. [Justin Robinson](#justin-robinson)
18. [Sam Rodgers-Melnick](#sam-rodgers-melnick)
19. [Miza Salim Hammoud](#miza-salim-hammoud)
20. [Akhil S.G.](#akhil-sg)
21. [Sriram Satyavolu](#sriram-satyavolu)
22. [Karlo Toljan](#karlo-toljan)

## General Notes

- In many cases, I have adjusted your title to improve it, and/or to meet the 80 character limit. Use this version of the title, or another I will like better that remains at a maximum of 80 characters.
- The next project-related deliverable is the [project update](https://thomaselove.github.io/500-2024/proj500.html#the-project-update) due Tuesday 2024-04-02 at 9 AM to Canvas. Some of you did an update as part of the second draft, for which I am grateful, but you'll need to submit a revised one by the April deadline.
- Don't miss the [analysis tips](https://thomaselove.github.io/500-2024/proj500.html#analysis-tips) within our project instructions.
- In preparing your **presentation**, follow [the outline and advice](https://thomaselove.github.io/500-2024/proj500.html#the-presentation) provided in the project instructions, please. Your slides and abstract need to be posted to our **Shared Drive** by Noon on the day **before** your presentation.

### Sara Alqahtani

Sara Alqahtani | Cybersecurity Breaches, Corporate Governance and Operational Performance
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class 13) 2024-04-18 from 10:45 to 11:10 AM
*Colleagues* | None
*Format* | Word/PDF
*Research ?* | 1. How do cybersecurity breaches affect the likelihood of leadership changes within companies? <br /> 2. What is the impact of cybersecurity breaches on the effectiveness of internal and disclosure controls?
*Outcome* | 1. Leadership change (binary) within a year of a breach (**but how do you measure that in non-breach companies?**) <br /> 2. Control Effectiveness (binary) within a year of a breach (**but how do you measure that in non-breach companies?**)
*"Treated"* | 876 companies that have experienced at least once cybersecurity breach
*"Control"* | 92395 companies which have not experienced a cybersecurity breach
*Covariates* | Revenue, Net Income, Book Value, Total Assets, Altman Z-score indicator of distress, Beneish M-score indicator of earnings manipulation risk, Market capitalization, Stock price, significant change in audit fees (**most are specified as one year prior to the breach, which again leaves me wondering how you assess this for the "untreated" group.**)
*Data Source* | Audit Analytics 2000-Feb 2024 records
*Also...* | -

[Back to Top](#table-of-contents)

### Naji Ayyash

Naji Ayyash | High air quality and its impact on physical and mental health
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class 14) 2024-04-25 from 8:30 to 8:55 AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### John Barron

John Barron | Lung Transplant Survival in Veterans of the US Armed Forces
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class 15) 2024-05-02 from 10:25 to 10:50 AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Seth Bauer

Seth Bauer | Vasopressor Cessation Order in the De-escalation Phase of Septic Shock
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class 15) 2024-05-02 from 9:25 to 9:50 AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Chris Benson

Chris Benson | Income inequality and Infant mortality in US counties
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Jesse Chen

Jesse Chen | Hypertension and Non-Alcoholic Fatty Liver Disease (NAFLD) Among Non-Obese US Adults
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Sid Dugar

Sid Dugar | Do early echocardiograms during sepsis and septic change outcomes?
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Ava Fan

Ava Fan | Imaging extranodal extension (iENE) as a prognostic factor in HPV+ oropharyngeal cancer
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Lent Mantshonyane

Lent Mantshonyane | The causal effect of tobacco smoking and biomass smoke on TB disease
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Marie Masotya

Marie Masotya | Asthma and School Absenteeism in Children on Medicaid in Cuyahoga County
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Morgan McLoughlin

Morgan McLoughlin | Maternal Depression and Parent-Training Participation and Engagement
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Lydia Mitchell

Lydia Mitchell | Health insurance and premature death in US adults
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Hala Nas

Hala Nas | Acute Respiratory Failure and Pneumothorax in Bronchoscopic Lung Volume Reduction
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Anya Nazarenko

Anya Nazarenko | Are men less likely to seek mental health treatment services?
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Anthony Orsino

Anthony Orsino | High School Drug Distribution and Social Health
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Aman Pande

Aman Pande | Interstitial lung diseases and immunosuppressant medications
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Justin Robinson

Justin Robinson | Biventricular Repair across the Spectrum of Atrioventricular Septal Defects (AVSD)
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Sam Rodgers-Melnick

Sam Rodgers-Melnick | Effectiveness of Music Therapy (MT) on Length of Stay and Opioid Utilization
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Miza Salim Hammoud

Miza Salim Hammoud | Gender-Specific Quality of Life in Adults with Congenital Heart Disease (ACHD)
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Akhil S.G.

Akhil S.G. | Telemedicine vs. Closing Time
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Sriram Satyavolu

Sriram Satyavolu | Food Insecurity and Depression Among U.S. Adults
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)

### Karlo Toljan

Karlo Toljan | Posterior reversible encephalopathy syndrome (PRES) and immunosuppressant history
:--------------: | :--------------------------------------------------------------------------------------------------
*Presenting* | (Class X) 2024-XX-XX from XX to XX AM
*Colleagues* | 
*Format* | 
*Research ?* | 
*Outcome* | 
*"Treated"* | 
*"Control"* | 
*Covariates* | 
*Data Source* | 
*Also...* | 

[Back to Top](#table-of-contents)
